Abbott Recalls Freestyle InsuLinx Glucose Meter Following Similar J&J Recall
This article was originally published in The Gray Sheet
Executive Summary
Abbott initiates a global recall of its FreeStyle InsuLinx blood glucose meter, after a similar recall of J&J/LifeScan glucose meter, due to device’s inaccurate reading at high blood glucose levels.
You may also be interested in...
Industry, FDA Coming Together On Risk Management For Marketed Devices
Online-Only Content >>> Representatives from the device industry and FDA are trying to establish common ground for how to assess and manage risk of potential safety or compliance issues that crop up for marketed devices.
Industry, FDA Coming Together On Risk Management For Marketed Devices
Representatives from the device industry and FDA are trying to establish common ground for how to assess and manage risk of potential safety or compliance issues that crop up for marketed devices.
Industry, FDA Coming Together On Risk Management For Marketed Devices
Representatives from the device industry and FDA are trying to establish common ground for how to assess and manage risk of potential safety or compliance issues that crop up for marketed devices.